By assigning lower ASCVD risk predictions, application of the PREVENT equations to existing treatment thresholds could reduce eligibility for statin and antihypertensive therapy among 15.8 million US adults. ja.ma/4fz1pbY

Terrific scientific discussion in JAMA about the new American Heart Association PREVENT equations for cardiovascular risk assessment With must read pieces by Sadiya Khan Don Lloyd-Jones jamanetwork.com/journals/jama/… And Jelani K. Grant Chiadi Ndumele Seth Martin jamanetwork.com/journals/jama/…

⏰Grateful for the opportunity to comment on the evolving landscape of CV🫀 risk assessment in JAMA with mentors 🔥 Chiadi Ndumele Seth Martin Link: jamanetwork.com/journals/jama/… What a wonderful study by James Diao Rishi Wadhera, MD MPP et al! Link: jamanetwork.com/journals/jama/…

Delighted to see promising data for AI outcome assessment in MASH - congrats to AndyBeck Ilan Wapinski @AmaroTaylorW and teams at PathAI! nature.com/articles/s4159…

The new cardiovascular disease risk calculator is better calibrated and more precise than its previous version, but may have unintended consequences for treatment bit.ly/3Sx5cg5

Excited to share that our paper on a foundation AI model for cancer prognosis and pathology diagnosis is published in Nature today. nature.com/articles/s4158… DBMI at Harvard Med NIH NIGMS CDMRP American Cancer Society #AI #DigitalPathology

Incredible article on reimagining DEI in medicine: • Renewed focus on SES • Targeting UPSTREAM barriers • Outcomes-centered innovation, not handwringing PR By the inimitable Simar Bajaj Ahmed Mukhtar Ahmed, MD Valerie Stone, MD